Literature DB >> 34010273

Current outlook after 4 years since the beginning of interventional cardiology in congenital heart disease in Chiapas State

Roberto Mijangos-Vázquez1, Rogelio Hernández-Reyes1.   

Abstract

Introduction: As a result of technological advances, more and more types of congenital heart diseases are susceptible to being treated in the hemodynamic laboratory. The sum of more advanced imaging techniques as well as the development of a diversity of devices specially manufactured for use in children has allowed a better selection of patients and therefore that many of them can be corrected through cardiac catheterization or some patients with more complex congenital heart diseases require fewer surgical procedures or, if they do require them, that these may be of less complexity and risk. Objective: We decided to show the global experience of the interventionism in congenital heart diseases in Chiapas from its inception to recent days.
Methods: Through a retrospective study from April 2016 to August 2020, we reviewed the electronic files of the total of patients who underwent cardiac catheterism during the same period of time.
Results: A total of 510 procedures were performed, 300 in female patients, with a median age of 4 years (8 days - 77 years). Of the total procedures, 67 (13.1%) were diagnostic catheterizations and 443 (86.9%) were interventional. Conclusions: Cardiac catheterization in congenital heart disease in Chiapas has become a very valuable option with encouraging results which represents a possible decentralization in the care of congenital heart diseases in our country.

Entities:  

Keywords:  Diagnostic catheterization; Interventional catheterization; Congenital heart disease; Chiapas

Mesh:

Year:  2022        PMID: 34010273      PMCID: PMC9005174          DOI: 10.24875/ACM.20000450

Source DB:  PubMed          Journal:  Arch Cardiol Mex        ISSN: 1665-1731


  13 in total

1.  [Intracardiac valvulotomy by means of a catheter].

Authors:  V RUBIO-ALVAREZ; R LIMON; J SONI
Journal:  Arch Inst Cardiol Mex       Date:  1953-04

2.  Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer Vascular Plug-II.

Authors:  Nancy Hua; Paolo Aquino; Carl Y Owada
Journal:  Cardiol Young       Date:  2015-10-26       Impact factor: 1.093

3.  Nonoperative closure of atrial septal defects.

Authors:  T D King; N L Mills
Journal:  Surgery       Date:  1974-03       Impact factor: 3.982

4.  Percutaneous closure of an acquired and iatrogenic left ventricular-right atrium communication (Gerbode defect) with an Amplatzer Vascular Plug II.

Authors:  Roberto Mijangos-Vázquez; Rogelio Hernández-Reyes; José R López-Jiménez
Journal:  J Cardiol Cases       Date:  2019-09-17

5.  [Congenital heart disease in Mexico. Regionalization proposal].

Authors:  Juan Calderón-Colmenero; Jorge Luis Cervantes-Salazar; Pedro José Curi-Curi; Samuel Ramírez-Marroquín
Journal:  Arch Cardiol Mex       Date:  2010 Apr-Jun

6.  Perimembranous Ventricular Septal Defect Device Closure: Choosing Between Amplatzer Duct Occluder I and II.

Authors:  Amal El-Sisi; R Sobhy; V Jaccoub; H Hamza
Journal:  Pediatr Cardiol       Date:  2017-03-01       Impact factor: 1.655

7.  Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System.

Authors:  W J Rashkind; C E Mullins; W E Hellenbrand; M A Tait
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

8.  Atrial septal defect closure with the new Cardia Ultrasept II™ device with interposed Goretex patch: Mexican experience - has the perforation of Ivalon's membrane been solved?

Authors:  Roberto Mijangos-Vázquez; Antonio J García-Montes; Elena M Soto-López; Verónica Guarner-Lans; Carlos Zabal
Journal:  Cardiol Young       Date:  2018-02-27       Impact factor: 1.093

9.  Transcatheter closure of ventricular septal defects.

Authors:  J E Lock; P C Block; R G McKay; D S Baim; J F Keane
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

10.  Transcatheter Closure of Perimembranous Ventricular Septal Defects Using Different Generations of Amplatzer Devices: Multicenter Experience.

Authors:  Roberto Mijangos-Vázquez; Amal El-Sisi; Juan P Sandoval Jones; José A García-Montes; Rogelio Hernández-Reyes; Rodina Sobhy; Antoine Abdelmassih; Mohammed M Soliman; Safaa Ali; Tatiana Molina-Sánchez; Carlos Zabal
Journal:  J Interv Cardiol       Date:  2020-02-21       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.